삼성바이오로직스

207940 코스피
1,710,000 9,000 (-0.52%)
기준 : 02/13
  • 시가총액
    791,575억
  • 주식수
    7,117만
  • PER
    49.60배
  • PBR
    6.50배
  • ROE
    13.10%
  • 결산월
    12월

25.4Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2025/12 2025/09 2025/06 2025/03 2024/12 2024/09 2024/06 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09 2019/06 2019/03 2018/12 2018/09 2018/06 2018/03 2017/12 2017/09 2017/06 2017/03 2016/12 2016/09 2016/06 2016/03 2015/12 2015/09 2015/06 2015/03 2014/12 2014/09 2014/06 2014/03 2013/12 2013/09 2013/06 2013/03 2012/12 2012/09
매출액(수익) 55,34155,341.0 55,04855,048.3 50,31650,316.9 48,98648,986.9 45,47345,473.2
내수 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 55,04855,048.3 50,31650,316.9 48,98648,986.9 45,47345,473.2
매출원가 N/AN/A 24,05424,054.2 23,67023,670.1 22,95122,951.6 22,56422,564.7
원재료 N/AN/A 10,78310,783.3 10,79810,798.5 9,9899,989.7 9,7789,778.7
재고자산의변동 N/AN/A -3,273-3,273.2 -3,222-3,222.3 -2,869-2,869.2 -2,472-2,472.4
기타원가 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
인건비 N/AN/A 5,5665,566.1 5,3555,355.3 5,1965,196.5 5,0805,080.1
감가상각비 N/AN/A 6,1166,116.6 5,8645,864.8 5,5895,589.4 5,4045,404.5
기타 N/AN/A 4,8614,861.3 4,8734,873.7 5,0455,045.2 4,7734,773.7
매출총이익 N/AN/A 30,99430,994.1 26,64626,646.7 26,03526,035.2 22,90822,908.4
판매비와관리비 N/AN/A 10,82610,826.1 10,38110,381.4 10,18010,180.8 9,7079,707.9
급여 N/AN/A 2,6602,660.1 2,5162,516.9 2,3732,373.9 2,2542,254.9
퇴직급여 N/AN/A 148148.4 141141.1 132132.1 125125.1
복리후생비 N/AN/A 544544.0 493493.0 461461.9 438438.0
임차료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수도광열비 N/AN/A 4646.4 4545.7 4545.2 4444.1
전산처리비 N/AN/A 501501.6 492492.5 491491.9 470470.2
지급수수료 N/AN/A 2,7342,734.9 2,6252,625.7 2,6512,651.8 2,6132,613.3
용역비 N/AN/A 3333.9 3535.5 3737.2 3131.8
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 165165.1 153153.7 165165.2 170170.4
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 1,7371,737.5 1,6901,690.9 1,5531,553.4 1,4461,446.4
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A -42-42.1 -122-122.1 -10-10.9 -63-63.8
감가상각비 N/AN/A 312312.4 348348.3 332332.3 325325.6
무형자산상각비 N/AN/A 163163.9 154154.5 142142.5 136136.2
기타 N/AN/A 1,8191,819.5 1,8051,805.3 1,8031,803.9 1,7151,715.0
영업이익 22,19322,193.8 20,16820,168.0 16,26516,265.3 15,85415,854.4 13,20013,200.5
EBITDA N/AN/A 27,20927,209.4 22,13822,138.8 22,37622,376.5 19,55319,553.7
금융손익 N/AN/A 748748.0 -83-83.7 904904.9 1,1161,116.5
금융수익 N/AN/A 3,3713,371.4 3,1923,192.2 3,5813,581.4 3,7223,722.2
이자수익 N/AN/A 526526.5 526526.3 546546.7 638638.3
외환거래이익 N/AN/A 2,6292,629.9 2,4662,466.9 2,8352,835.9 2,8712,871.9
외환차익 N/AN/A 1,8271,827.6 2,0262,026.9 2,0652,065.1 1,8801,880.7
외화환산이익 N/AN/A 802802.2 440440.0 770770.8 991991.1
기타 N/AN/A N/AN/A 00.0 00.0 00.0
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가이익 N/AN/A 1111.3 1313.5 55.9 55.9
파생상품이익 N/AN/A 203203.5 185185.3 192192.6 205205.9
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 N/AN/A 2,6232,623.4 3,2763,276.0 2,6762,676.4 2,6052,605.6
이자비용 N/AN/A 529529.5 439439.7 438438.8 500500.5
외환거래손실 N/AN/A 2,1252,125.6 2,8692,869.6 2,2502,250.9 2,1002,100.5
외환차손 N/AN/A 1,9151,915.9 2,1492,149.8 2,2842,284.4 1,8861,886.3
외화환산손실 N/AN/A 209209.7 719719.8 -33-33.5 214214.1
기타 N/AN/A 00.0 00.0 00.0 00.0
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A -31-31.8 -33-33.3 -13-13.3 44.6
기타 N/AN/A 00.0 00.0 00.0 00.0
기타영업외손익 N/AN/A -603-603.8 -632-632.2 -652-652.6 -643-643.1
기타영업외수익 N/AN/A 103103.4 7272.4 5454.6 4747.5
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A 00.0 00.0 00.0 00.0
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A 66.3 66.4 66.3 66.3
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A 88.9 1010.2 88.7 33.8
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 8888.0 5555.7 3939.4 3737.3
기타영업외비용 N/AN/A 707707.2 704704.6 707707.2 690690.7
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A 4646.5 4747.8 4646.8 3939.3
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 3232.1 2828.2 3131.9 2222.8
무형자산처분손실 N/AN/A 22.9 22.9 22.9 22.9
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A 617617.7 617617.7 617617.7 617617.7
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 77.9 77.8 77.7 77.7
종속기업및관계기업관련손익 N/AN/A 180180.9 183183.7 186186.9 2626.6
지분법손익 N/AN/A 180180.9 183183.7 186186.9 2626.6
지분법이익 N/AN/A 179179.0 180180.7 185185.7 2626.6
지분법손실 N/AN/A 11.8 22.9 11.2 00.0
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 11.8 183183.7 186186.9 2626.6
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 N/AN/A 20,49320,493.1 15,73315,733.0 16,29316,293.6 13,70013,700.5
법인세비용 N/AN/A 4,5344,534.1 2,8742,874.0 3,4983,498.5 2,8672,867.3
중단사업이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
당기순이익 17,27417,274.5 15,95815,958.9 12,85912,859.0 12,79512,795.0 10,83310,833.1
지배지분 순이익 N/AN/A 15,95815,958.9 12,85912,859.0 12,79512,795.0 10,83310,833.1
비지배지분 순이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익 N/AN/A -80-80.2 -114-114.3 -96-96.3 -91-91.3
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
해외사업환산손익 N/AN/A 3535.2 11.4 1919.4 2424.3
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A -115-115.4 -115-115.8 -115-115.8 -115-115.6
총포괄이익 N/AN/A 15,87815,878.6 12,74412,744.7 12,69812,698.7 10,74110,741.8
지배지분 총포괄이익 N/AN/A 15,87815,878.6 12,74412,744.7 12,69812,698.7 10,74110,741.8
비지배지분 총포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
주당순이익 N/AN/A 22,42222,422.4 18,06718,067.0 17,97717,977.1 15,22015,220.6
시가총액 N/AN/A 709,604709,604.7 706,046706,046.0 721,704721,704.3 675,441675,441.2
주가 N/AN/A 1,467,3291,467,329.0 1,459,9701,459,970.0 1,492,3481,492,348.0 1,396,6851,396,685.0
주가수익배수 N/AN/A 44.4644.46 54.9154.91 56.4056.40 62.3562.35
주식수(만주) N/A 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 6,696 6,696 6,696 6,696 6,696 6,696 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

20년 재무제표를 한번에! 프리미엄 서비스를 무제한으로 이용하세요. 프리미엄 55% 평생할인

밸류라인 서비스를 무제한 이용하세요 프리미엄